Close
Nordic 9Nordic 9

Walleye Capital (investor - Others)

United States walleyecapital.com
See something wrong or missing? Let us know
Offices:Minneapolis

Walleye Capital is an American technology-driven investment advisor headquartered in Minnesota that manages $3.9B of investor capital predominantly through two core multi-strategy hedge funds..

Average round investment:64.75M USD
Average number per year:1.0
Distribution: 2024 (1)2022 (1)
Portfolio companies: Belgium Agomab
Mostly invests in: Belgium Belgium (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Walleye Capital

Name Criteria
United States Driehaus Capital Management
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cormorant Asset Management
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Redmile Group
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Belgium Ackermans & van Haaren
72%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Sanofi Ventures
71%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland BioMedPartners
71%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States Fearless Ventures
70%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Leonard Green & Partners L.P.
70%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
70%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States 5AM Ventures
70%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top